1,648 results on '"Yamagishi, Sho-ichi"'
Search Results
2. Effects of olmesartan and amlodipine on blood pressure, endothelial function, and vascular inflammation
3. Glucose-Dependent Insulinotropic Polypeptide Inhibits AGE-Induced NADPH Oxidase-Derived Oxidative Stress Generation and Foam Cell Formation in Macrophages Partly via AMPK Activation †.
4. DNA Aptamer raised against Advanced Glycation End Products Improves Sperm Concentration, Motility, and Viability by Suppressing RAGE-induced Oxidative Stress and Inflammation in Testes of Diabetic Mice
5. Effects of omarigliptin on glucose variability and oxidative stress in type 2 diabetes patients: A prospective study
6. New Estimation Formulas for Daily Sodium Intake in Hemodialysis Patients by a Duplicate Portion Method
7. Diabetes and Female Sterility/Infertility
8. Diabetes and Advanced Glycation End Products
9. Glucose Variability is Independently Correlated with Serum Level of Pigment Epithelium-Derived Factor in Type 2 Diabetes
10. DNA Aptamer Raised against Advanced Glycation End Products Improves Sperm Concentration, Motility, and Viability by Suppressing Receptors for Advanced Glycation End Product-Induced Oxidative Stress and Inflammation in the Testes of Diabetic Mice.
11. Two-hour postload plasma glucose and pigment epithelium-derived factor levels are markers of coronary artery inflammation in type 2 diabetic patients
12. A Clinical Case of Probable Sitosterolemia
13. Subcutaneous Infusion of DNA-Aptamer Raised against Advanced Glycation End Products Prevents Loss of Skeletal Muscle Mass and Strength in Accelerated-Aging Mice
14. Triple combination therapy with telmisartan, amlodipine, and hydrochlorothiazide ameliorates albuminuria in a normotensive rat remnant kidney model
15. Relationship between glucose variability evaluated by continuous glucose monitoring and clinical factors, including glucagon-stimulated insulin secretion in patients with type 2 diabetes
16. Glycolaldehyde-modified advanced glycation end-products inhibit differentiation of human monocytes into osteoclasts via upregulation of IL-10
17. Association of Hemoglobin A1c, 1,5-Anhydro-d-Glucitol and Glycated Albumin with Oxidative Stress in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study
18. Comparison of Effects of Injectable Semaglutide and Dulaglutide on Oxidative Stress and Glucose Variability in Patients with Type 2 Diabetes Mellitus: A Prospective Preliminary Study
19. Prospective randomized comparative study of the effect of pemafibrate add‐on or double statin dose on small dense low‐density lipoprotein‐cholesterol in patients with type 2 diabetes and hypertriglyceridemia on statin therapy
20. Minodronate
21. Association of skin autofluorescence with plaque vulnerability evaluated by optical coherence tomography in patients with cardiovascular disease
22. Mechanism for the Development of Bone Disease in Diabetes: Increased Oxidative Stress and Advanced Glycation End Products
23. High serum soluble tumor necrosis factor receptor 1 predicts poor treatment response in acute-stage schizophrenia
24. High doses of antipsychotic polypharmacy are related to an increase in serum levels of pentosidine in patients with schizophrenia
25. Association of advanced glycation end products with sarcopenia and frailty in chronic kidney disease
26. Concerns about clinical efficacy and safety of warfarin in diabetic patients with atrial fibrillation
27. Circulating level of pigment epithelium-derived factor is associated with vascular function and structure: A cross-sectional study
28. Clinical Feasibility and Monitoring of the Effects of Anti-inflammatory Therapy in Atherosclerosis
29. Comparison of positive rates between glutamic acid decarboxylase antibodies and ElisaRSR ™ 3 Screen ICA ™ in recently obtained sera from patients who had been previously diagnosed with slowly progressive type 1 diabetes
30. SMTP-44D Inhibits Atherosclerotic Plaque Formation in Apolipoprotein-E Null Mice Partly by Suppressing the AGEs-RAGE Axis
31. Pathologic role of dietary advanced glycation end products in cardiometabolic disorders, and therapeutic intervention
32. An Overview on Diabetic Nephropathy
33. List of Contributors
34. Luseogliflozin attenuates neointimal hyperplasia after wire injury in high-fat diet-fed mice via inhibition of perivascular adipose tissue remodeling
35. Dipeptidyl peptidase-4 deficiency protects against experimental diabetic nephropathy partly by blocking the advanced glycation end products-receptor axis
36. Evaluation of tissue accumulation levels of advanced glycation end products by skin autofluorescence: A novel marker of vascular complications in high-risk patients for cardiovascular disease
37. Serum levels of pigment epithelium-derived factor (PEDF) are inversely associated with circulating levels of dipeptidyl peptidase-4 (DPP-4) in humans
38. Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice
39. Compared effects of calcium and sodium polystyrene sulfonate on mineral and bone metabolism and volume overload in pre-dialysis patients with hyperkalemia
40. Maternal exposure to high-fat and high-fructose diet evokes hypoadiponectinemia and kidney injury in rat offspring
41. Effect of statins on the serum soluble form of receptor for advanced glycation end-products and its association with coronary atherosclerosis in patients with angina pectoris
42. Sulforaphane inhibits advanced glycation end product–induced pericyte damage by reducing expression of receptor for advanced glycation end products
43. DNA aptamer raised against advanced glycation end products inhibits melanoma growth in nude mice
44. Pigment Epithelium–Derived Factor Improves Metabolic Derangements and Ameliorates Dysregulation of Adipocytokines in Obese Type 2 Diabetic Rats
45. DNA aptamer raised against advanced glycation end products inhibits neointimal hyperplasia in balloon-injured rat carotid arteries
46. Pathological Role of AGEs in Osteoporosis
47. Diabetes and Advanced Glycation End Products
48. Diabetes and Female Sterility/Infertility
49. Abstract 11702: Vascular Function is Impaired in Subjects With Decreased Circulating Level of Pigment Epithelium-derived Factor
50. Comparison of positive rates between glutamic acid decarboxylase antibodies and ElisaRSR™ 3 Screen ICA™ in recently obtained sera from patients who had been previously diagnosed with slowly progressive type 1 diabetes.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.